Biogen Inc (NASDAQ:BIIB) over-valued by 11%
Website | https://www.biogen.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2020 |
Market Cap | $41,449,299,968 |
Beta | 0.436845 |
Average Volume | $1,154,198 |
Last Dividend | 0% |
Price on Apr 22, 2021 | $275.31 |
Autochartist™ Valuation | $245.13 |
Conclusion |
11% over-valued |
Download Report |